Terns Pharmaceuticals Inc (NASDAQ: TERN) on Tuesday, plunged -3.59% from the previous trading day, before settling in for the closing price of $4.46. Within the past 52 weeks, TERN’s price has moved between $4.16 and $11.40.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
It was noted that within the last five years, the titan of the Healthcare sector saw sales slided by -25.00%. The company achieved an average annual earnings per share of 6.27%. With a float of $62.32 million, this company’s outstanding shares have now reached $84.92 million.
The extent of productivity of a business whose workforce counts for 66 workers is very important to gauge. In terms of profitability, gross margin is 47.35%, operating margin of -7562.78%, and the pretax margin is -6641.75%.
Terns Pharmaceuticals Inc (TERN) Insider and Institutional Ownership
Observing investor behavior towards Biotechnology industry stocks is more important than anything else. The insider ownership of Terns Pharmaceuticals Inc is 26.63%, while institutional ownership is 75.26%. The most recent insider transaction that took place on Nov 30 ’24, was worth 11,498. In this transaction Chief Business Officer of this company bought 2,250 shares at a rate of $5.11, taking the stock ownership to the 2,250 shares. Before that another transaction happened on Nov 30 ’24, when Company’s Chief Executive Officer bought 510 for $5.11, making the entire transaction worth $2,606. This insider now owns 19,609 shares in total.
Terns Pharmaceuticals Inc (TERN) Latest Financial update
According to the Wall Street analysts, stocks earnings will be around 6.27% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will plunge by -4.53% during the next five years compared to -12.40% drop over the previous five years of trading.
Terns Pharmaceuticals Inc (NASDAQ: TERN) Trading Performance Indicators
Terns Pharmaceuticals Inc (TERN) is currently performing well based on its current performance indicators. A quick ratio of 32.99 was reported for the most recent quarter.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -1.18, a number that is poised to hit -0.30 in the next quarter and is forecasted to reach -1.32 in one year’s time.
Technical Analysis of Terns Pharmaceuticals Inc (TERN)
The latest stats from [Terns Pharmaceuticals Inc, TERN] show that its last 5-days average volume of 1.66 million was inferior to 1.84 million than last year’s volume. As of the previous 9 days, the stock’s Stochastic %D was 38.78%. Additionally, its Average True Range was 0.29.
During the past 100 days, Terns Pharmaceuticals Inc’s (TERN) raw stochastic average was set at 2.07%, which indicates a significant decrease from 22.50% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 64.01% in the past 14 days, which was higher than the 62.72% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $5.45, while its 200-day Moving Average is $6.87. Now, the first resistance to watch is $4.42. This is followed by the second major resistance level at $4.53. The third major resistance level sits at $4.63. If the price goes on to break the first support level at $4.21, it is likely to go to the next support level at $4.11. The third support level lies at $4.00 if the price breaches the second support level.
Terns Pharmaceuticals Inc (NASDAQ: TERN) Key Stats
Market capitalization of the company is 365.24 million based on 84,939K outstanding shares. Right now, sales total 0 K and income totals -90,210 K. The company made 0 K in profit during its latest quarter, and -21,950 K in sales during its previous quarter.
